From: Allard, Crystal
Sent: Friday, May 27, 2011 10:24 AM
To: 'Urs Aeberli'
Subject: Kedrion 125384/0 - Information Request
I have another last minute information request for you:
This is to further clarify our position with regard to reprocessing of a manufacturing step, and also to provide you a feedback on Amendment # 14 that you have submitted to your BLA in reference to reprocessing. Please note that reprocessing of certain manufacturing steps, such as re-filtration may be allowed if supported by sufficient validation data that have been reviewed and found acceptable by CBER. If validation data has not yet been submitted, you may request reprocessing of a given step in your manufacturing process and submit the validation data as a supplement, upon approval of your current BLA.
Please respond by the end of the day, Monday May 30. We can discuss this in Tuesday's Telecon, if necessary.
Crystal Allard, RAC
Regulatory Project Manager
U.S. Food & Drug Administration
CBER/ OBRR/ DBA/RPMB
WOC1; RM480N; HFM-380
1401 Rockville Pike
Rockville, MD 20852
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this communication is not authorized. If you have received this document in error, please notify the sender immediately by e-mail or phone.